Curet Myriam 4

4 · INTUITIVE SURGICAL INC · Filed Mar 2, 2026

AI-generated summary of this filing

Updated Mar 2, 2026

Intuitive Surgical (ISRG) CMO Myriam Curet Sells Shares

What Happened

Myriam Curet, Executive Vice President & Chief Medical Officer of Intuitive Surgical, reported a mix of transactions around February 27–28, 2026. She sold 2,345 shares in an open‑market transaction on 2026-02-27 at $499.71 per share for proceeds of $1,171,820. On 2026-02-28 she exercised/converted vested equity awards (PSUs/RSUs) resulting in acquisition entries for 1,002 and 8,378 shares and related tax‑withholding dispositions of 497 shares ($250,244) and 4,155 shares ($2,092,084). Total cash proceeds shown on the Form 4 equal about $3.51 million. Overall this filing reflects vested award conversions and routine sales/withholdings rather than a new open‑market purchase.

Key Details

Transaction dates and amounts:
- 2026-02-27: Open‑market sale — 2,345 shares @ $499.71 = $1,171,820 (code S).
- 2026-02-28: Exercise/conversion of derivatives — 1,002 and 8,378 shares acquired (code M; $0 exercise price shown because these are equity award conversions).
- 2026-02-28: Tax withholding / payment of exercise price or tax liability — 497 shares @ $503.51 = $250,244 and 4,155 shares @ $503.51 = $2,092,084 (code F).
- Some derivative entries (M) also show dispositions at $0 reflecting the conversion/settlement mechanics of the awards.
Shares owned after the reported transactions: Not stated in the provided filing details.
Notable footnotes:
- F1: The 2/27 open‑market sale was executed under a Rule 10b5‑1 trading plan that expires July 29, 2026.
- F2/F5: RSUs vest 25% annually over four years and convert one‑for‑one into common stock on the vest date.
- F3: PSUs granted 2/28/2023 vested (performance targets met) and vested on 2/28/2026 subject to continued service.
- F4: The F‑coded transactions represent shares withheld to cover taxes on the PSU settlement.
Filing timeliness: No late filing flag indicated in the provided information.

Context

These transactions appear to be primarily award vesting and routine tax withholding, plus a prearranged sale under a 10b5‑1 plan. For retail investors, sales driven by tax withholding or trading plans are usually administrative/routine rather than a direct expression of new confidence or concern about the company. The M (exercise/conversion) and F (tax withholding) codes show the awards vested and were converted to common stock, with some shares withheld to satisfy tax obligations and some sold under the trading plan.

Form 4

Period: 2026-02-27

EVP & Chief Medical Officer

Transactions

Sale
Common Stock
[F1]
2026-02-27$499.71/sh−2,345$1,171,820→ 409 total(indirect: By Trust)
Exercise/Conversion
Common Stock
[F2]
2026-02-28+1,002→ 1,411 total(indirect: By Trust)
Tax Payment
Common Stock
[F2]
2026-02-28$503.51/sh−497$250,244→ 914 total(indirect: By Trust)
Exercise/Conversion
Common Stock
[F3]
2026-02-28+8,378→ 9,292 total(indirect: By Trust)
Tax Payment
Common Stock
[F4]
2026-02-28$503.51/sh−4,155$2,092,084→ 5,137 total(indirect: By Trust)
Exercise/Conversion
Performance Stock Units - 2-28-2023
[F3]
2026-02-28−8,378→ 0 total
Exercise: $0.00→ Common Stock (8,378 underlying)
Exercise/Conversion
Restricted Stock Units
[F5]
2026-02-28−1,002→ 0 total
Exercise: $0.00Exp: 2026-02-28→ Common Stock (1,002 underlying)

Footnotes (5)

[F1]The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
[F2]RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
[F3]Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
[F4]This transaction represents the withholding of shares to cover taxes applicable to a settlement of PSUs reported on this Form 4.
[F5]Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

Signature

By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet|2026-03-02

1 file